This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Price to Sales Ratio of Natus Medical Incorporated with missing and latest data points interpolated. Price to Sales Ratio is figured by comparing Natus Medical Incorp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Natus Medical sales, a figure that is much harder to manipulate than other Natus Medical Incorporated multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. An alternative calculation method to [PS], that measures the ratio between a company's Adjusted Share Price and it's Sales per Share.
|10 Years Trend|
Compare to Other EquitiesAll Fundamental Data
Natus Medical Price to Sales Ratio Over Time